A carregar...
Trastuzumab Beyond Progression in Retrospective Analyses: An Issue of Equal Opportunities
Results of the Hermine study of trastuzumab beyond progression in breast cancer patients, published by Extra and colleagues in The Oncologist, are re-examined and an alternative explanation for the dismal postprogression survival time of patients stopping therapy is presented.
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228112/ https://ncbi.nlm.nih.gov/pubmed/21393343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0329 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|